Emergent Manufacturing Operations Baltimore LLC. – FDA 483, Apr 20, 2020
EMERGENT MANUFACTURING OPERATIONS BALTIMORE LLC, a contract testing laboratory in Baltimore, MD, was cited for significant deficiencies during an FDA inspection. The observations primarily concern severe data integrity issues, including unprotected electronic data, unreviewed audit trails, and manual manipulation of records. Additionally, the firm failed to follow established laboratory procedures, ensure adequate quality control unit oversight, provide proper employee training, and correctly manage rejected materials.
- Inspection date
- April 20, 2020
- Product type
- drugs
ID · b5041727-3d40-40b0-a2dc-af7868d4e480
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.